the team

Rob Harris

Board Member

Rob Harris

Board Member

Mr. Harris has served as a member of the Board of Directors of Aralez Pharmaceuticals Inc. since February 5, 2016. Mr. Harris has over 35 years of pharmaceutical industry experience in both Canada and the United States in sales, marketing, business development and general management. Mr. Harris most recently served as President and CEO of Tribute Pharmaceuticals. Prior to co-founding Tribute Pharmaceuticals, Rob was the President & CEO of Legacy Pharmaceuticals Inc. Mr. Harris also has previous experience at Biovail Corporation where as VP of Business Development he was involved, led and successfully concluded numerous business development transactions, including the licensing of new chemical entities, the acquisition of mature products, the completion of co-promotion deals, distribution agreements, product development and reformulation transactions. Before joining Biovail, Mr. Harris spent twenty years with Wyeth-Ayerst (now Pfizer) in sales and various senior management positions including two years in the animal health business.

highlights
  •  Board of Director of Aralez Pharmaceuticals Inc. since February 5, 2016
  •  Over 35 years of pharmaceutical industry experience in both Canada and the United States
  • Recently served as President and CEO of Tribute Pharmaceuticals
  • Past  President & CEO of Legacy Pharmaceuticals Inc.
  • Held a senior position at Biovail Corporation as VP of Business Development
  •  Spent twenty years with Wyeth-Ayerst (now Pfizer) in various senior management positions including two years in the animal health business.